Lung CT densitometry in systemic sclerosis: Correlation with lung function, exercise testing, and quality of life

Chest

Volumn 131, Issue 3, 2007, Pages 672-681

  Camiciottoli, Gianna ^a   Orlandi, Ilaria ^a   Bartolucci, Maurizio ^a   Meoni, Eleonora ^a   Nacci, Francesca ^b   Diciotti, Stefano ^a   Barcaroli, Chiara ^a   Conforti, Maria Letizia ^a   Pistolesi, Massimo ^a   Matucci Cerinic, Marco ^a   Mascalchi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Università degli Studi di Firenze ^*

Author keywords

CT; Densitometry; Histogram analysis; Pulmonary function tests; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG DIFFUSION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCIBILITY; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS;

EID: 33947424398     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1401     Document Type: Article

References (37)

1. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46:428-440.
2. Weaver AL, Divertie MB, Titus JL. Pulmonary scleroderma. Dis Chest 1968; 54:490-498
3. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118:2-10
4. Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992; 47:738-742
5. Wells AU, Rubens MB, du Bois RM, et al. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol 1993; 161:1159-1165
6. Wells AU, Hansell DM, Rubens MB, et al. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148:1076-1082
7. Kahaleh MB. Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004; 22(suppl 33):S19-S23
8. Cailes JB, du Bois RM, Hansell DM. Density gradient of the lung parenchyma at computed tomographic scanning in patients with pulmonary hypertension and systemic sclerosis. Acad Radiol 1996; 3:724-730
9. Hachulla E, Gressin V, Guillevin L, et al, Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52:3792-3800
10. Le Roy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998; 15:202-205
11. Remy-Jardin M, Remy J, Wallaert B, et al. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests and bronchoalveolar lavage. Radiology 1993; 188:499-506
12. Hansell DM. High resolution computed tomography in the evaluation of fibrosing alveolitis. Clin Chest Med 1999; 20:739-760
13. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum 1997; 40:1229-1236
14. Warrick JH, Bhalla M, Schabel SI, et al. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991; 18:1520-1528
15. Eaton T, Young P, Milne D, et al. Six minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171:1150-1157
16. Khanna D, Clements PJ, Furst DE, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005; 52:592-600
17. Valentini G, Silman AJ, Veale D. Assessment of disease activity [abstract]. Clin Exp Rheumatol 2003; 21(suppl 29): S39-S41
18. McGoon M, Gutterman D, Steen V, et al. Screening, early detection and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(suppl):S14-S34
19. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(suppl):S40-S70
20. Denton CP, Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36:239-243
21. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40:1984-1991
22. Mahler DA, Weinberg DH, Wells CK, et al. The measurements of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85:751-758
23. American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117
24. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
25. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique; 1995 update. Am J Respir Crit Care Med 1995; 152:2185-2198
26. Moroni C, Mascalchi M, Camiciottoli G, et al. Comparison of spirometric-gated and -ungated HRCT in COPD. J Comput Assist Tomogr 2003; 27:375-379
27. Best AC, Lynch AM, Bozic CM, et al. Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. Radiology 2003; 228:407-414
28. Altman DG. Some common problems in medical research. In: Altman DG, ed. Practical statistics for medical research. Boca Raton, FL: Chapman & Hall/CRC, 1999; 396-408
29. STROBE statement: Strengthening the Reporting of Observational Studies in Epidemiology. Available at: www. strobe-statement.org. Accessed November 20, 2006
30. Kazerooni EA. High-resolution CT of the lungs. AJR Am J Roentgenol 2001; 177:501-519
31. Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994; 49:236-240
32. Tanaka N, Newell JD, Brown KK, et al. Collagen vascular disease-related lung disease: high resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 2004; 28:351-360
33. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232:560-567
34. Wells AU, Rubens MB, du Bois RM, et al. Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography. Eur Respir J 1997; 10:280-285
35. Chan TY, Hansell DM, Rubens MB, et al. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997; 52:265-270
36. Diot E, Boissinot E, Asquier E, et al. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 1998; 114:1623-1629
37. Sverzellati N, Zompatori M, De Luca G, et al. Evaluation of quantitative CT indexes in idiopathic interstitial pneumonias using a low-dose technique. Eur J Radiol 2005; 56:370-375